Exploring the Frontier of Stem Cell Technology: Century Therapeutics’ Latest Breakthroughs at ASGCT 2024
Century Therapeutics is making significant strides in the field of stem cell therapy, particularly with their induced pluripotent stem cell (iPSC) technology, which was showcased at the 2024 ASGCT Annual Meeting. The company presented compelling preclinical data, emphasizing advancements in treating autoimmune diseases and enhancing the survivability of allogeneic cell therapies against natural killer (NK) […]
Revolutionizing Treatment: Century Therapeutics and FUJIFILM’s Groundbreaking Alliance to Combat Autoimmune Diseases with Stem Cell Therapies
In a significant development for the treatment of autoimmune and inflammatory diseases, Century Therapeutics, Inc., a trailblazing biotechnology company, and FUJIFILM Cellular Dynamics, Inc., a prominent developer and manufacturer of human induced pluripotent stem cells (iPSCs) and iPSC-derived cells, have announced a worldwide license agreement. This collaboration is set to advance the development and commercialization […]
Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
PHILADELPHIA, Jan. 04, 2023 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that Lalo Flores, Ph.D., Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 9:45 AM PT. A live webcast of […]